skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: In view of the GBT acquisition, expected increase in revenues, what would be a fair price based on the industry average PE ratios, at the end of 2020 ? Do you think GUD will remain in the dog house for investors much longer ? I would have thought the GBT acquisition would have have changed investor sentiment, but clearly has not. What needs to happen to move the stock ?
Thanks
Read Answer Asked by Luc on June 01, 2020
Q: Stagflation is beginning to be mentioned as a medium term possibility. What sector(s) provide best protection against this and could see growth? Can you recommend an ETF or two (if a handful of individual companies would be better, please recommend a couple instead). Thank you in advance.
Read Answer Asked by John on June 01, 2020
Q: I have pretty much thought of GUD as a long, long term hold, and one that would be good to have in a market crisis when they could put their cash to work efficiently. But there it was and they didn't. Its starting to feel like aside from being generally close to book value, there is not much to see here. Have you had reason to rethink your position on GUD? Thank-you.
Read Answer Asked by Alex on May 27, 2020
Q: Hi Peter and Staff
In my US Healthcare basket I currently own PFE , JNJ,STYK, and MDT
a)Are there other US Healthcare names that you would substitute for any of the 4 as part of a basket?

b) I also own CSH.UN and SIA and love the dividends and am hopeful of a price jump based on your previous replies of that beaten up sector getting to the other side. In a basket approach are there other names in the US that would warrant a trimming of either of those two or of SIS or GUD to own on a long term basis total return dividends and capital gains?

Thanks for all you do
Dennis
Read Answer Asked by Dennis on May 26, 2020
Q: Please rank the above in terms of return potential and risk. Feel free to exclude one if the comparison is too difficult. Thanks in advance!
Read Answer Asked by Brenda on May 20, 2020
Q: This is a follow up question to my earlier question.
From a risk profile point of view, please classify each of the above companies as:
Low risk, average risk, high risk or speculative. Charge as many questions as you feel appropriate.
Thanks. RAM
Read Answer Asked by Ray on May 05, 2020
Q: Please comment on STC's update after close today. 2)GC closed $9m overallotment option of $180m unsecured debenture.What's the impact if any. 3)Gud stated that there will be a delay in filing its Q1,2020 due to covid-19.Please comment. Txs for u usual great services & views
Read Answer Asked by Peter on May 04, 2020
Q: I have multiple questions. Please charge accordingly:
What is Freehold's revised dividend? Time to buy now?
Please comment on Vermillion results. Time to buy at $6?
What is Knight's revised shareholder account after 12M share buyback?
Is Lightspeed rebounding too fast or would you step in now?
Thank you.
Read Answer Asked by Steven on April 29, 2020
Q: Wow your team is good!

I am short in health care in my portfolio. Can you please provide me with your current five favourite health care buys for growth over the next five years. I am comfortable with volatility, Canada or US, and small, medium or large cap.

Thanks in advance

Read Answer Asked by Brian on April 20, 2020
Q: According to StockCharts, GUD has increased 32.45% in the past month. The only stock in your Balanced Equity portfolio that is down is NFI, down 27.45%. My question is, re NFI why? Should we be patient? Can we see NFI rebound when the pandemic subsides and people start moving around again?
Read Answer Asked by Fred on April 17, 2020
Q: In answer to @Cheryl, Knight released two news yesterday. The Triumvira repayment shows that Goodman's strategy of battling mostly 'singles' (except the GBT 'homerun') is working.

However, a more meaningful news is that Knight finished repurchasing 100% of their shares buyback under their NCIB. I don't recall a company actually buying "all" of the NCIB allocation. We knew they had bought 78% of it as of March 30, 20 in their Q4 2019 quarterly report. We could have expected they would buy the other 18% but still did it quickly with Stock having dropped a lot in the COVID market (even though they said COVID had not affected their business - well not yet at least).

Question: their NCIB only expires on July 8. Does it mean GUD has to wait until July 8 to request another NCIB to the TSX if they want to continue buying back their shares? Medison still owns 7.5% (10.5M shares) of the company, and I would really like to have GUD arrange a 'block' buyback of Medison's Shares via a 'special NCIB' repurchase to finish the Meir Jacobson involvement once and for all without disrupting the share price, or at least causing uncertainty/concern on that.

Is that possible? And if so, does it have to wait until current NCIB expires in July even as they have completed 100% of the current NCIB already? Thank you!
Read Answer Asked by Jennifer on April 17, 2020
Q: The current volatility and fear in the market has lead me to believe there will be some companies that will unnecessarily be punished/caught in the crossfire and therefore offer a great risk/return
could you please list out companies in your mind that have decreased significantly unfairly and/or offer a compelling risk/return in the US or Canadian Markets
thank you
Read Answer Asked by cary on April 06, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!